Now, with data showing progesterone inhibition of tumor growth, it makes it reasonable to perform more detailed mechanistic studies to help define the interaction of nuclear progesterone receptor with nuclear FoxO1 activity in GBM. The gene discussed is FOXO1; the disease is glioblastoma.